Archives of Pharmacal Research

, Volume 33, Issue 5, pp 647–654

Antimicrobial activity of new 4,6-disubstituted pyrimidine, pyrazoline, and pyran derivatives

  • Mahmoud M. M. Ramiz
  • Wael A. El-Sayed
  • Asmaa I. El-Tantawy
  • Adel A. -H. Abdel-Rahman
Research Articles Drug Design

Abstract

A number of new 2,6-didisubstituted pyrimidine, pyrazoline, and pyran derivatives were synthesized starting from their chalcone derivative. The synthesized compounds displayed different degrees of antimicrobial activity against Bscillus subtilis (Gram-positive), Pseudomonas aeruginosa (Gram-negative), and Streptomyces species (Actinomycetes).

Key words

Pyrimidines Pyrazolines Pyrans Antimicrobial activity 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abdel-Rahman, A. A.-H., El-Sayed, W. A., Abdel-Bary, H. M., Abdel-Megied, A. E.-S., and Morcy, E. M., Amino acid derivatives. VIII. synthesis and antimicrobial evaluation of a-amino acid esters bearing an indole side chain. Monatsh. Chem., 139, 1095–1101 (2008).CrossRefGoogle Scholar
  2. Agarwal, A., Srivastava, K., Puri, S. K., and Chauhan P. M., Synthesis of 2,4,6-trisubstituted pyrimidines as antimalarial agents. Bioorg. Med. Chem., 13, 4645–4650 (2005).CrossRefPubMedGoogle Scholar
  3. Atwal, K., Preparation of 2-amino dihydropyrimidin-5-carboxylates as cardiovascular agents. U.S. Patent, 4769371, Sept. 6, 1988.Google Scholar
  4. Bedair, A. H., El-Haddy, N. A., Abd El-Latif, M. S., Fakery, A. H., and El-Agrody, A. M., 4-Hydroxycoumarin in heterocyclic synthesis: Part III. Synthesis of some new pyrano[2,3-d]pyrimidine, 2-substituted[1,2,4]-triazolo[1,5-c] pyrimidine and pyrimido [1,6-b][1,2,4]triazine derivatives. Farmaco, 55, 708–714 (2000).CrossRefPubMedGoogle Scholar
  5. Bianchi, G. and Tava, A., Synthesis of (2R)(+)-2,3-dihydro-2,6-dimethyl-4H-pyran-4-one, a homologue of pheromones of a species in the hepialidae family, Agric. Biol. Chem., 51, 2001–2002 (1987).Google Scholar
  6. Boyd, D. B., Theoretical and Physicochemical Studies on b-Lactam Antibiotics. In Morin, R. B., Gorman, M. (Eds.). b-Lactam Antibiotics, Chemistry and Biology. Academic Press, New York, Vol. 1, pp. 437–545, (1982).Google Scholar
  7. Brown, D., In Katritzky, A. R., Rees, C. W. (Eds.). Comprehensive Heterocyclic Chemistry II. Pergamon Press, Oxford, Vol. 3, Chapter 2.13 (1996).CrossRefGoogle Scholar
  8. Capdeville, R., Buchdunger, E., Zimmermann, J., and Matter, A., Glivec (ST1571, imatinib), a rationally developed targeted anti cancer drug. Nat. Rev. Drug Discov., 1, 493–502 (2002).CrossRefPubMedGoogle Scholar
  9. Chang, L. C. W., Spanjersberg, R. F., von Frijtag Drabbe Kunzel, J. K., Mulder-Krieger, T., van denHout, G., Beukers, M. W., Brussee, J., and Jzerman, A. P., 2,4,6-Trisubstituted pyrimidines as a new class of selective adenosine A1 receptor antagonists. J. Med. Chem., 47, 6529–6540 (2004).CrossRefPubMedGoogle Scholar
  10. Dell, C. P. and Smith, C. W., Antiproliferative derivatives of 4H naphtho[1,2-b]pyran and process for their preparation. Eur. Patent, 537949, Apr. 21, 1993.Google Scholar
  11. Eiden, F. and Denk, F., Synthesis and CNS activity of pyran derivatives: 6,8-dioxabicyclo (3,2,1) octane. Arch. Pharm. (Weinheim), 324, 353–354 (1991).CrossRefGoogle Scholar
  12. El-Sayed, W. A., Ramiz, M. M. M., and Abdel-Rahman, A. A.-H., C-Furyl glycosides. I. Synthesis and antimicrobial evaluation of C-furyl glycosides and chalcones derived therefrom. Monatsh. Chem., 139, 1499–1505 (2008).CrossRefGoogle Scholar
  13. El-Sayed, W. A., Nassar, I. F., and Abdel-Rahman, A. A.-H., C-Furyl glycosides. II. Synthesis and antimicrobial evaluation of C-furyl glycosides bearing pyrazolines, isoxazolines, and 5,6-dihydropyrimidine-2(1H)-thiones. Monatsh. Chem., 140, 365–370 (2009).CrossRefGoogle Scholar
  14. El-Agrody, A. M., Abd El-Latif, M. S., El-Hady, N. A., Fakery, A. H., and Bedair, A. H., Heteroaromatization with 4-hydroxycoumarin. Part II. Synthesis of some new pyrano[2,3-d][1,2,4]triazolo[1,5-c]-pyrimidines and pyrimido [1,6-b][1,2,4]triazine derivatives, Molecules, 6, 519–527 (2001).CrossRefGoogle Scholar
  15. El-Agrody, A. M., El-Hakim, M. H., Abd El-Latif, M. S., Fakery, A. H., El-Sayed, E. M., and El-Ghareab, K. A., Synthesis of pyrano[2,3-d]pyrimidine and pyrano[3,2-e][1,2,4]triazolo[2,3-c]pyrimidine derivatives with promising antibacterial activities. Acta Pharm., 50, 111–120 (2000).Google Scholar
  16. Gadhachanda, V. R., Wu, B., Wang, Z., Kuhen, K. L., Caldwell, J., Zondler, H., Walter, H., Havenhand, M., and He, Y., 4-Aminopyrimidines as novel HIV-1 inhibitors. Bioorg. Med. Chem. Lett., 17, 260–265 (2007).CrossRefPubMedGoogle Scholar
  17. Gholap, A. R., Toti, K. S., Shirazi, F., Deshpande, M. V., and Srinivasan, K. V., Efficient synthesis of antifungal pyrimidines via palladium catalyzed Suzuki/Sonogashira crosscoupling reaction from Biginelli 3,4-dihydropyrimidin 2(1H)-ones. Tetrahedron, 64, 10214–10223 (2008).CrossRefGoogle Scholar
  18. Grant, N., Mishriky, N., Asaad, F. M., and Fawzy, N. G., Pyridines and pyrazolines from salicylic acid derivatives with propenone residue and their antimicrobial properties. Pharmazie, 53, 543–547 (1998).PubMedGoogle Scholar
  19. Greenwood, Antimicrobial Chemotherapy, 4th ed, Oxford University press, New York, pp. 114, (2000).Google Scholar
  20. Hegab, M. I., Hassan, N. A., Rashad, A. E., Fahmy, A. A., and Abdel-Megeid, F. M. E., Synthesis, reactions, and antimicrobial activity of some fused thieno[2,3-d]pyrimidine derivatives. Phosphorus Sulfur Silicon Relat. Elem., 182, 1535–1556 (2007).CrossRefGoogle Scholar
  21. Hiramoto, K., Nasuhara, A., MichiLoshi, K., Kato, T., and Kikugawa, K., DNA strand-breaking activity and mutagenicity of 2,3-dihydro-3,5-dihydroxy-6-methyl-4H-pyran-4-one (DDMP), A Maillard reaction product of glucose and glycine. Mutat. Res., 395, 47–56 (1997).PubMedGoogle Scholar
  22. Janssen, A. M., Scheffer, J. J., and Svendsen, A. B., Antimicrobial activity of essential oils; a 1976–1986 literature review. Planta Med., 53, 395–400 (1987).CrossRefPubMedGoogle Scholar
  23. Jorgensen, J. H., Jurnide, J. D., and Washington, J. A., Antimicrobial susceptibility tests. In Muarry, P. R., Baron, E. J., and Yolken, R. C. (Eds.). Manual of Clinical Microbiology, 7th ed. American Society for Microbiology, Washington, DC, pp. 1526–1543, (1999).Google Scholar
  24. Jungheim, L. N., Holmes, R. E., Ott, J. L., Ternansky, R. J., Draheim, S. E., Neel D. A., Stepherd, T. A., and Sigmund, S. K., Abstracts of 26th Interscience Conference on Antimicrobial Agents and Chemotherapy, Sept. 28–Oct. 1, New Orleans, L.A., paper 601 (1988a).Google Scholar
  25. Jungheim, L. N., Holmes, R. E., Ternansky, R. J., Stepherd, T. A., Neel, D. A., Draheim, S. E., Pike, A. J., and Wu, C. Y. E., Abstracts of 28th Interscience Conference on Antimicrobial Agents and Chemotherapy, Oct. 23–26, Los Angels, C.A., paper 240 (1988b).Google Scholar
  26. Jungheim, L. N., Sigmund, S. K., and Fisher, J. W., Bicyclic pyrazolidinones, a new class of antibacterial agent based on the β-lactam model. Tetrahedron Lett., 28, 285–288 (1987a).CrossRefGoogle Scholar
  27. Jungheim, L. N., Sigmund, S. K., Jones, N. D., and Swartzendruber, J. K., Bicyclic pyrazolidinones, steric and electronic effects on antibacterial activity. Tetrahedron Lett., 28, 289–292 (1987b).CrossRefGoogle Scholar
  28. Keutzberger, A. and Gillessen, X., Antimykotische Wirkstoffe, 18. Mitt. Aromatisch substituierte 2-(4-Toluidino)pyrimidine J. Arch. Pharm., 318, 370–374 (1985).CrossRefGoogle Scholar
  29. Martinez, A. G. and Marco, L. J., Friedlander reaction on 2-amino-3-cyano-4H-pyrans, synthesis of derivatives of 4Hpyran[ 2,3-b]quinoline, new tacrine analogues. Bioorg. Med. Chem. Lett., 7, 3165–3170 (1997).CrossRefGoogle Scholar
  30. Matloobi, M. and Kappe, C. O., Microwave-assisted solution- and solid-phase synthesis of 2-amino-4-arylpyrimidine derivatives. J. Comb. Chem., 9, 275–284 (2007).CrossRefPubMedGoogle Scholar
  31. Nasr, M. N. A. and Said, S. A., Novel 3, 3a, 4, 5, 6, 7-hexahydroindazole and arylthiazolylpyrazoline derivatives as anti-inflammatory agents. Arch. Pharm. Pharm. Med. Chem., 336, 551–559 (2003).CrossRefGoogle Scholar
  32. Nauduri, D. and Reddy, G. B., Antibacterials and antimycotics. Part 1. Synthesis and activity of 2-pyrazoline derivatives. Chem. Pharm. Bull., 46, 1254–1260 (1998).PubMedGoogle Scholar
  33. Ozeki, K., Ichikawa, T., Takehara, H., Tanimura, K., Sato, M., and Yaginuma, H., Studies on antiallergy agents. III. Synthesis of 2-anilino-1,6-dihydro-6-oxo-5-pyrimidinecarboxylic acids and related compounds. Chem. Pharm. Bull., 37, 1780–1787 (1989).PubMedGoogle Scholar
  34. Shishoo, C. J., Devani, M. B., Ullas, G. V., Ananthan, S., and Bahadit, V. S., Studies in the synthesis and interconversion of isomeric triazolopyrimidines. J. Heterocycl. Chem., 18, 43–46 (1981).CrossRefGoogle Scholar
  35. Taylor, N. R., Cleasby, A., Singh, O., Skarzynski, T., Wonacott, A. J., Smith, P. W., Sollis, S. L., Howes, P. D., Cherry, P. C., Bethell, R., Colman, P., and Varghese, J., Dihydropyrancarboxamides related to zanamivir: A new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus types A and B. J. Med. Chem., 41, 798–807 (1998).CrossRefPubMedGoogle Scholar
  36. Ternansky, R. J. and Draheim, S. E., [3.3.0] Pyrazolodinones: An efficient synthesis of a new class of synthetic antibacterial agents. Tetrahedron Lett., 31, 2805–2808 (1990).CrossRefGoogle Scholar
  37. Turan-Zitouni, G., Chevallet, P., Kilic, F. S., and Erol, K., Synthesis of some thiazolyl-pyrazoline derivatives and preliminary investigation of their hypotensive activity. Eur. J. Med. Chem., 35, 635–641 (2000).CrossRefPubMedGoogle Scholar
  38. Turan-Zitouni, G., Ozdemir, A., and Guven, K., Synthesis of some 1-[(N,N-disubstitutedthiocarbamoylthio)acetyl]-3-(2-thienyl)-5-aryl-2 pyrazoline derivatives and investigation of their antibacterial and antifungal activities. Arch. Pharm. Pharm. Med. Chem., 338, 96–104 (2005a).CrossRefGoogle Scholar
  39. Turan-Zitouni, G., Ozdemir, A., Kaplanclkll, Z. A., Chevallet, P., and Tunalý, Y., Synthesis and Antimicrobial Activities of Some 1-[(N,N-disubstituted-thiocarbamoylthio)acetyl]-3,5-diaryl-2-pyrazolines. Phosphorus Sulfur Silicon Relat. Elem., 180, 2717–2724 (2005b).CrossRefGoogle Scholar
  40. Zaki, M. E. A., Soliman, H. A., Hiekal, O. A., and Rashad, A. E., Pyrazolopyranopyrimidines as a class of anti inflammatory agents. Z. Naturforsch. C, 61c, 1–5 (2006).Google Scholar

Copyright information

© The Pharmaceutical Society of Korea and Springer Netherlands 2010

Authors and Affiliations

  • Mahmoud M. M. Ramiz
    • 1
  • Wael A. El-Sayed
    • 2
    • 4
  • Asmaa I. El-Tantawy
    • 1
  • Adel A. -H. Abdel-Rahman
    • 3
  1. 1.Department of Physics and Mathematical Engineering, Faculty of Electronic EngineeringMenoufia UniversityMenoufEgypt
  2. 2.Department of PhotochemistryNational Research CentreCairoEgypt
  3. 3.Department of Chemistry, Faculty of ScienceMenoufia UniversityShebin El-KoamEgypt
  4. 4.Department of PhotohemistryNational Research CenterCairoEgypt

Personalised recommendations